Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in: September 2024

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Innovative Medicines Canada/Médicaments novateurs Canada

Bettina Hamelin, President (Organization)

Results 1-28 of 28

  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Foreign Affairs, Health, Infrastructure, International Trade, Research and Development, Science and Technology, Small Business, Taxation and Finance
    Communication date: 2024-09-26
    Posted date: 2024-10-11
    Communication number: 371-616925 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jessica Fullerton , Senior Policy Advisor | Office of the Minister of Intergovernmental Affairs | Infrastructure Canada (INFC)

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology, Small Business, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616901 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Yash Nanda, Deputy Director of Policy to the Deputy Prime Minister and Minister of Finance of Canada | Finance Canada (FIN)

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616885 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nicholas Kang, Senior Policy Advisor | Policy and Cabinet Affairs | Prime Minister's Office (PMO)

    Subject Matter of the communication: Agriculture, Consumer Issues, Federal-Provincial Relations, Health, Infrastructure, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616884 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ya'ara Saks, Minister of Mental Health and Addictions, and Associate Minister of Health | House of Commons
    • Michelle Boudreau, Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616883 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616880 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Marie-Françoise Mégie, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616877 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Shuvaloy Majumdar, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Foreign Affairs, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616874 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Valerie Bradford, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616873 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Federal-Provincial Relations, Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology, Small Business, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616872 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chandra Arya, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616870 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Earl Dreeshen, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616867 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Corey Tochor, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616863 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Denis Garon, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616861 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Bernard Généreux, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616859 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jade Mallette , Director of Parliamentary Affairs | Office of the Minister of Health | Health Canada (HC)
    • Ehsan Naik, Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Federal-Provincial Relations, Foreign Affairs, Health, Infrastructure, Intellectual Property, International Trade, Research and Development, Science and Technology, Small Business, Taxation and Finance
    Communication date: 2024-09-24
    Posted date: 2024-10-11
    Communication number: 371-616911 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Matt Jeneroux, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616827 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Tony Baldinelli, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616824 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Helena Jaczek, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616823 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Yasir Naqvi, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616822 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616821 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Adam Chambers, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616816 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Foreign Affairs, Health, Infrastructure, Intellectual Property, International Trade, Research and Development, Science and Technology, Small Business, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616856 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Chris Forbes, Deputy Minister of Finance | Finance Canada (FIN)
    • Alison O'Leary, Senior Assistant Deputy Minister | Infrastructure Canada (INFC)

    Subject Matter of the communication: Agriculture, Consumer Issues, Federal-Provincial Relations, Foreign Affairs, Health, Infrastructure, Intellectual Property, International Trade, Research and Development, Science and Technology, Small Business, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616845 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rechie Valdez, Minister of Small Business | House of Commons
    • Christiana Osei, Digital Media and Communications Advisor to Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Ajay Rakhra, Senior Advisor, Ontario and Stakeholder Relations to the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    • Chris Zhou, Acting Director of Policy to the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616839 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Kim Pate, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616836 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Peter Fragiskatos, Member of Parliament | House of Commons

    Subject Matter of the communication: Constitutional Issues, Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616834 View monthly communication report
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Francis Scarpaleggia, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Foreign Affairs, Health, Infrastructure, Intellectual Property, International Trade, Research and Development, Science and Technology, Small Business, Taxation and Finance
    Communication date: 2024-09-23
    Posted date: 2024-10-11
    Communication number: 371-616830 View monthly communication report

Return to Monthly Communication Reports by Reporting Period

Date Modified: